Viking Therapeutics: Buyers Are Quietly Accumulating On Its Obesity Drugs Launch Potential [Seeking Alpha]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Seeking Alpha
VKTX's dual-track pipeline and manufacturing agreements position it to rapidly scale commercialization upon regulatory approval, despite a volatile and competitive GLP-1 market. Management's flexible go-to-market strategy and recent commercial leadership appointment highlight readiness to compete independently or via partnership. Wall Street projects VKTX could exceed $1.4B in revenue by 2030, with a visible cash runway and potential for earlier profitability supporting the investment thesis. Looking for a helping hand in the market? Members of Ultimate Growth Investing get exclusive ideas and guidance to navigate any climate. Learn More » Olga Yastremska/iStock via Getty Images I have closely observed the market sentiments underlining the recovery and advance of the stock of Viking Therapeutics, Inc. ( VKTX ) for some time. And I've come away confident that the wave of selling that More on my IG service A Growth Investing Service To Help You Outperform I'm a firm bel
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics (VKTX) Valuation Check After Q4 2025 Earnings And Obesity Pipeline Progress [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics (NASDAQ:VKTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- Viking Therapeutics Inc (VKTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Rising ... [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics plans to advance oral obesity drug to late-stage trial [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 2/11/26 - Miss
VKTX
Sec Filings
- 2/11/26 - Form 10-K
- 2/11/26 - Form 8-K
- 1/26/26 - Form 4
- VKTX's page on the SEC website